carbamates has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deadwyler, SA; Hampson, RE; Miller, F; Palchik, G | 1 |
| Lee, CY; Lee, ML; Liou, HH; Shih, CC | 1 |
2 other study(ies) available for carbamates and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticity.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arachidonic Acids; Benzamides; Benzoxazines; Calcium; Cannabinoid Receptor Modulators; Carbamates; Endocannabinoids; Glycine; Hippocampus; In Vitro Techniques; Morpholines; Naphthalenes; Neuronal Plasticity; Neurons; Phosphorylation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Ryanodine Receptor Calcium Release Channel; Second Messenger Systems | 2011 |
Carisbamate (RWJ-333369) inhibits glutamate transmission in the granule cell of the dentate gyrus.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anticonvulsants; Biophysics; Calcium Channel Blockers; Carbamates; Dentate Gyrus; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; In Vitro Techniques; Male; Neurons; omega-Conotoxin GVIA; Patch-Clamp Techniques; Picrotoxin; Rats; Rats, Wistar; Synaptic Transmission | 2011 |